FDA accepts application for Roche’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Across four phase III studies, approximately half of patients receiving faricimab could extend treatment time…
Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion